|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.75 EUR | +1.57% |
|
+2.48% | -4.43% |
| 12-09 | Oddo BHF Maintains Negative Stance on Eramet Despite Raised Target | |
| 12-04 | ERAMET S.A. - Special Call |
| Capitalization | 1.45B 1.69B 1.35B 1.26B 2.33B 151B 2.54B 15.69B 6.11B 71.8B 6.32B 6.19B 264B | P/E ratio 2025 * |
-5.28x | P/E ratio 2026 * | -13.5x |
|---|---|---|---|---|---|
| Enterprise value | 3.18B 3.7B 2.97B 2.78B 5.12B 333B 5.57B 34.46B 13.43B 158B 13.89B 13.6B 579B | EV / Sales 2025 * |
1.06x | EV / Sales 2026 * | 0.94x |
| Free-Float |
28.55% | Yield 2025 * |
2.94% | Yield 2026 * | 2.65% |
Last Transcript: Eramet
| 1 day | +0.59% | ||
| 1 week | +1.49% | ||
| Current month | -4.38% | ||
| 1 month | -2.75% | ||
| 3 months | +10.74% | ||
| 6 months | +7.26% | ||
| Current year | -5.36% |
| 1 week | 49.5 | 52.45 | |
| 1 month | 48.6 | 55.45 | |
| Current year | 38.74 | 66.7 | |
| 1 year | 38.74 | 66.7 | |
| 3 years | 38.74 | 114.5 | |
| 5 years | 38.74 | 166 | |
| 10 years | 15.36 | 167.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 2025-05-25 | |
| Director of Finance/CFO | 54 | 2025-09-14 | |
| Chief Operating Officer | 58 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 2011-05-10 | |
| Director/Board Member | 69 | 2016-09-22 | |
| Director/Board Member | 58 | 2011-05-10 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.59% | +1.49% | -6.39% | -35.78% | 1.69B | ||
| +1.26% | +4.98% | +7.82% | -5.01% | 150B | ||
| +1.32% | +3.26% | +11.61% | -0.11% | 128B | ||
| -0.76% | +0.44% | +57.57% | +111.51% | 70.78B | ||
| -1.16% | -0.17% | +11.75% | +29.99% | 62.21B | ||
| +0.71% | +0.07% | -0.03% | -28.70% | 59.54B | ||
| +0.47% | -1.86% | -0.01% | -19.18% | 41.43B | ||
| +4.36% | +5.80% | +312.30% | +240.74% | 27.25B | ||
| +1.92% | +3.57% | +4.79% | +64.89% | 24.1B | ||
| +0.93% | -0.70% | +5.76% | +71.30% | 22.78B | ||
| Average | +0.96% | +0.38% | +40.52% | +42.96% | 58.75B | |
| Weighted average by Cap. | +0.80% | +1.27% | +27.58% | +27.53% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.99B 3.48B 2.8B 2.61B 4.82B 313B 5.24B 32.42B 12.63B 148B 13.07B 12.79B 545B | 3.4B 3.96B 3.18B 2.97B 5.49B 356B 5.97B 36.9B 14.38B 169B 14.87B 14.56B 620B |
| Net income | -276M -322M -258M -241M -445M -28.92B -485M -3B -1.17B -13.71B -1.21B -1.18B -50.31B | -108M -126M -101M -94.33M -174M -11.3B -189M -1.17B -456M -5.36B -472M -462M -19.66B |
| Net Debt | 1.73B 2.02B 1.62B 1.51B 2.79B 181B 3.04B 18.77B 7.31B 85.9B 7.57B 7.41B 315B | 1.75B 2.04B 1.63B 1.53B 2.82B 183B 3.07B 18.96B 7.39B 86.75B 7.64B 7.48B 318B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-11 | 51.75 € | +1.57% | 29,691 |
| 25-12-10 | 50.95 € | +0.89% | 27,186 |
| 25-12-09 | 50.50 € | -1.46% | 47,044 |
| 25-12-08 | 51.25 € | +0.20% | 22,913 |
| 25-12-05 | 51.15 € | +1.29% | 31,884 |
Real-time Euronext Paris, December 11, 2025 at 11:11 am
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ERA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















